MOBIX LABS, INC (MOBX): Nasdaq/NYSE listing notice — Mobix Labs gets Nasdaq extension to Apr 2026; reclasses $6.3M warrants to equity

MOBIX LABS, INC

Nasdaq extended bid-price compliance deadline to April 27, 2026; company previously met $1.00 for 10 days on Sept 11, 2025.
Amended warrants for 13,375,490 shares to reclassify ~$6.3M from liability to equity; also issued 1M-share warrant at $1.08.
Debt-for-equity swaps: issued 227,954 shares to Acromax for $204,931 and 687,894 shares to Alessandra for $510,792.
Company believes stockholders' equity now exceeds $5M, satisfying Nasdaq Capital Market initial listing standard.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.98

MOBIX LABS, INC received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: noncompliance notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

April 28, 2025 from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with the minimum bid-price requirement for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid-Price Requirement”). The notice provided the Company 180 calendar days, or until October 27, 2025, to regain compliance by maintaining a closing bid price of at least $1.00 per share for a minimum of ten consecutive business days, as provided in Nasdaq Listing Rule 5810(c)(3)(A) (the “Initial Compl

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

MOBIX LABS, INC filing history →

Source: SEC EDGAR

accession 0001493152-25-020249

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.